SCHEMBL9998130

SCHEMBL9998130

CCCc1cccc(C=C(Cc2ccccc2)C(OC(C)=O)OC(C)=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 1/20 0.40
LTB4R Q15722 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.38
POLB P06746 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
PPARG P37231 1/20 0.36
ALDH1A1 P00352 5/20 0.36
CYP1A2 P05177 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
KAT6A Q92794 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998129 1.00 CYP3A4 (0.40) CYP3A4CYP2C9TSHRLTB4RLTB4R2
SCHEMBL9997453 0.93 HDAC4 (0.42) CYP3A4CYP2C9TSHRLTB4RLTB4R2
SCHEMBL9997451 0.93 HDAC4 (0.42) CYP3A4CYP2C9TSHRLTB4RLTB4R2
SCHEMBL9997711 0.90 TSHR (0.42) CYP3A4CYP2C9TSHRLTB4RLTB4R2
SCHEMBL9997710 0.90 TSHR (0.42) CYP3A4CYP2C9TSHRLTB4RLTB4R2
SCHEMBL9998379 0.89 CYP4F2 (0.37) CYP3A4CYP2C9LTB4RLTB4R2PTGES
SCHEMBL9998380 0.89 CYP4F2 (0.37) CYP3A4CYP2C9LTB4RLTB4R2PTGES
SCHEMBL9997718 0.88 TSHR (0.42) CYP3A4CYP2C9TSHRPOLBALDH1A1
SCHEMBL9997716 0.88 TSHR (0.42) CYP3A4CYP2C9TSHRPOLBALDH1A1
SCHEMBL9997924 0.88 CYP4F2 (0.36) PTGESALOX5PPARGALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP3A4 36/4885CYP2C9 28/4885TSHR 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.